Tofflon Science and Technology Group Co., Ltd. (SZSE: 300171)
Health Care · Health Care Equipment & Supplies · CN
CN¥16.43
+3.14% today · +12.5% 1Y
Tofflon Science and Technology Group Co., Ltd. (SZSE: 300171) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $1.86B and employs 5,479 people.
Over the last twelve months the share price has gained 12.5%, trading between 10.42 and 20.37.
Tweenvest scores Tofflon Science and Technology Group Co., Ltd. across four factors: quality 72/100, value 43/100, growth 27/100, dividend 27/100. Its strongest factor is quality.
300171 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.86B
- Revenue (TTM)
- $785.98M
- P/E
- 48.33
- EPS
- 0.34
- Dividend yield
- 0.89%
- Beta (5Y)
- 0.28
- 52-week high
- CN¥20.37
- 52-week low
- CN¥10.42
- Avg volume (3M)
- —
- Shares outstanding
- 760.85M
- Employees
- 5,479
- Next earnings
- —
About Tofflon Science and Technology Group Co., Ltd.
Tofflon Science and Technology Group Co., Ltd., originally established in 1993 as Shanghai Tofflon Science and Technology Co., Ltd. and headquartered in Shanghai, China, serves as a global purveyor of sophisticated equipment for the pharmaceutical and biotechnology sectors. The company's diverse offerings encompass specialized machinery for injectable drug manufacturing, including automated systems for solution preparation, aseptic filling lines tailored for ampoules, vials, syringes, and powders, along with freeze dryers featuring automatic loading capabilities, barrier systems, and plastic packaging machines. Beyond equipment, Tofflon also supplies active pharmaceutical ingredients and provides essential quality control systems such as visual inspection, leak detection, and integrated combination units. Furthermore, Tofflon is a significant provider of bio-process equipment and comprehensive integrated systems. These solutions cover various stages, from medium and buffer preparation to cell/microbial cultivation, harvesting, diafiltration/ultrafiltration (DF/UF), purification, and final filling processes. The company also offers specialized laboratory services for lyophilization of injectables.
- ISIN
- CNE100000ZP0
- Founded
- 1993
- Listed since
- Feb 1, 2011
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Insight Lifetech Co., Ltd.SHSE: 688712 | $1.92B | CN¥30.92 | -0.96% |
| Shandong Weigao Blood Purification Products Co., Ltd.SHSE: 603014 | $1.92B | CN¥30.79 | -1.16% |
| Establishment Labs Holdings Inc.NasdaqCM: ESTA | $1.90B | $63.85 | -2.21% |
| Shandong Weigao Group Medical Polymer Company LimitedSEHK: 1066 | $1.88B | HK$3.25 | -1.37% |
| Vimian Group AB (publ)OM: VIMIAN | $1.85B | Skr34.95 | -0.99% |
| LeMaitre Vascular, Inc.NasdaqGM: LMAT | $1.81B | $79.31 | +0.33% |
| Angelalign Technology Inc.SEHK: 6699 | $1.81B | HK$83.20 | -0.72% |
| Shandong Pharmaceutical Glass Co.LtdSHSE: 600529 | $1.80B | CN¥18.17 | -0.16% |
Figures last refreshed Oct 4, 2026.